About this episode:

This week, President Trump signed an Executive Order aimed at lowering prescription drug costs. In this episode: a look at why the U.S. spends three to four times more for drugs than many peer countries, its current approach to drug pricing policy, the directives laid out in the Executive Order, and how other countries negotiate their prices. Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

Guest:

Dr. Gerard Anderson is an expert in health policy and a professor in Health Policy and Management and International Health at the Johns Hopkins Bloomberg School of Public Health.

Host:

Stephanie Desmon, MA, is a former journalist, author, and the director of public relations and communications for the Johns Hopkins Center for Communication Programs at the Johns Hopkins Bloomberg School of Public Health.

Show links and related content:

• Delivering Most-Favored Nation Prescription Drug Pricing to American Patients—Executive Order, The White House

• The Potential Impacts of Cuts to Medicaid—Public Health On Call (March 2025)

• What’s Next For Prescription Drug Pricing?—Public Health On Call (February 2023)

Transcript information:

Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel.

Contact us:

Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website.

Follow us:

• @‌PublicHealthPod on Bluesky

• @‌JohnsHopkinsSPH on Instagram

• @‌JohnsHopkinsSPH on Facebook

• @‌PublicHealthOnCall on YouTube

• Here's our RSS feed